Redmile Group, LLC Logic Bio Therapeutics, Inc. Transaction History

Redmile Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$7.01 - $11.01 $5.25 Million - $8.25 Million	-749,026 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$6.97 - $13.46 $459,127 - $886,637	-65,872 Reduced 8.08%	749,026 $8.1 Million
Q2 2019 Aug 14, 2019	SELL	$9.77 - $17.08 $927,065 - $1.62 Million	-94,889 Reduced 10.43%	814,898 $10.6 Million
Q1 2019 May 15, 2019	SELL	$7.93 - $10.41 $11,895 - $15,615	-1,500 Reduced 0.16%	909,787 $8.99 Million
Q4 2018 Feb 14, 2019	BUY	$7.88 - $17.98 $7.18 Million - $16.4 Million	911,287 New	911,287 $9.48 Million

Ticker LOGC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,962,700
Description
LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company's GeneRide technology is a new approach to precise gene insertion harnessing a cell's natural deoxyribonucleic acid; and gene delivery platform, sAAVy is...

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Redmile Group, LLC with notifications on news.